1 completed, 1 not yet recruiting. 2 Phase 2, 1 Phase 1.
| Phase | Trials | Status |
|---|---|---|
| Phase 2 | 2 | Completed 1, Not yet recruiting 1 |
| Phase 1 | 1 | Completed 1 |
Follow SARS CoV-2: new trials by email Literature Review of SARS CoV-2 trials Research Report on SARS CoV-2
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| mRNA Covid-19 Vaccine Immune Response Comparisons Using Different Delivery Routes COMIRNATY® - Evaluate Immune Responses Following mRNA COVID-19 Vaccine Administration Through Different Delivery Routes in Healthy Volunteers, SARS CoV-2 | Phase 2 | Not yet recruiting | PharmaJet, Inc. | 40 | 2025-05-01 | 2025-04-15 |
| Safety and Feasibility of Amniotic Fluid as a Treatment for COVID-19 Patients Human Amniotic Fluid - SARS CoV-2 | Phase 1 / Phase 2 | Completed | University of Utah | 47 | 2020-10-28 | 2023-12-21 |
COVID-19 (1)
Coronaviridae Infections (1) · Coronavirus Infections (1) · Infections (1) · Lung Diseases (1) · Nidovirales Infections (1) · Pneumonia (1) · Pneumonia, Viral (1) · RNA Virus Infections (1) · Respiratory Tract Diseases (1) · Respiratory Tract Infections (1) · Virus Diseases (1)
BNT162 Vaccine (1) · amniotic fluid peptide-1, human (1)
PharmaJet, Inc. (1) · University of Utah (1)
United States (2)